|
Post by fldave007 on Aug 5, 2019 16:11:34 GMT -5
Okay What do we have to do to increase prescription numbers? No needles is great isn't it? I mean who would rather take a freaking shot. Lower A 1c, just as effective or more so than any other diabetes medication. Less hypo's sleep throughout night with less worries of never waking up again. FDA approved study cohort for 4-7 year olds would FDA allow this if they were really worried about stupid blackbox warnings. What bullshit those warnings are. This drug should be a homerun are endocrinologists stupid and lazy? They have taken a hippocratic oaththat dictates to do whats best for patients. What am I missing the stock price is wprse than ridiculous it is criminal.
|
|
|
Post by sportsrancho on Aug 5, 2019 16:14:06 GMT -5
I talked to somebody yesterday whose son goes to a hottie toddy Endo ..he can’t get on Afrezza either.. he said it’s so incredibly political. It’s like parents wanting to get their kids into the best school they want them to have these high sought after Endo’s but once you get in there you can’t change the system you have to do what he wants you to do.
|
|
|
Post by lifebreath on Aug 5, 2019 16:19:15 GMT -5
I talked to somebody yesterday whose son goes to a hottie toddy Endo ..he can’t get on Afrezza either.. he said it’s so incredibly political. It’s like parents wanting to get their kids into the best school they want them to have these high sought after Endo’s but once you get in there you can’t change the system you have to do what he wants you to do. do you think it is just political or does it have to do with money and perks Endos receive for prescribing the big three?
|
|
|
Post by lojothehus on Aug 5, 2019 16:24:15 GMT -5
For some odd reason, Afrezza continues to be a depressed stock. The Shorts are having a field day depressing this stock and keeping it where they want it. Sometimes they say that there is a bigger picture, but it makes you wonder...doesn't it. My question is this??? and maybe the answer is in the question: If Afrezza is such a good insulin as you say it is; If it's somewhat safe for children 4-7 years old; if it lowers A1C's; all of this, and if it's the first effective treatment to Diabetes oh yeah and let me put the ribbon on it, WITHOUT A NEEDLE!
WHY ARE THE NATIONAL TALK SHOWS AND NEWS OUTLETS SO QUIET? WHY ARE THE ENDOS, DOCTORS, AND PHARMACIES SO QUIET?
Why is everyone so quiet???
OK, frustration has been released.
|
|
|
WTF
Aug 5, 2019 16:37:08 GMT -5
Post by ktim on Aug 5, 2019 16:37:08 GMT -5
Okay What do we have to do to increase prescription numbers? No needles is great isn't it? I mean who would rather take a freaking shot. Lower A 1c, just as effective or more so than any other diabetes medication. Less hypo's sleep throughout night with less worries of never waking up again. FDA approved study cohort for 4-7 year olds would FDA allow this if they were really worried about stupid blackbox warnings. What bullshit those warnings are. This drug should be a homerun are endocrinologists stupid and lazy? They have taken a hippocratic oaththat dictates to do whats best for patients. What am I missing the stock price is wprse than ridiculous it is criminal. You seem to recognize that the problem is docs not prescribing. While there is probably a lot of variance as to why many don't, it probably comes down to them not interpreting the known data in the same way you do. Lazy and stupid could be flaws that would cause a doc to misinterpret data. How prevalent that is might depend on how one chooses to define those words. Would a doc not wanting to deal with hassles of special approvals for drugs be lazy? Would a doc wanting to see the long term safety trials required by FDA before prescribing widely be stupid? Would a doc that followed the dosing literature provided by the manufacturer and saw suboptimal outcomes be stupid or lazy?
|
|
|
WTF
Aug 5, 2019 16:55:25 GMT -5
Post by lennymnkd on Aug 5, 2019 16:55:25 GMT -5
Safety trails . We’ve been around fifteen yrs / the rest takes effort ‘ s they don’t need to take at this stage of the game / but one day will !
|
|
|
Post by sayhey24 on Aug 5, 2019 17:10:45 GMT -5
I talked to somebody yesterday whose son goes to a hottie toddy Endo ..he can’t get on Afrezza either.. he said it’s so incredibly political. It’s like parents wanting to get their kids into the best school they want them to have these high sought after Endo’s but once you get in there you can’t change the system you have to do what he wants you to do. do you think it is just political or does it have to do with money and perks Endos receive for prescribing the big three? Its both. For afrezza to sell via normal channels the SOC needs to be updated. Dr. Kendall has over 60 studies showing why afrezza should be Step 1 in T2 care. Is it even mentioned with RAA use in the SOC? This is partially political but also driven my money. Have afrezza as Step 1 and T2s do not progress to Steps 2 through 4. There will no longer be a need for all the orals, SGLT2 and GLP1s. There will also no longer be a need for all the doctors specializing in neuropathy and other diabetes specialties. Afrezza would have a huge financial impact and the ADA would lose significant financial support from BP and probably go bankrupt. Then you have the social aspect. A lot of doctors are pals with their BP sales reps and like all the perks they can offer.
|
|
|
Post by lifebreath on Aug 5, 2019 17:20:48 GMT -5
do you think it is just political or does it have to do with money and perks Endos receive for prescribing the big three? Its both. For afrezza to sell via normal channels the SOC needs to be updated. Dr. Kendall has over 60 studies showing why afrezza should be Step 1 in T2 care. Is it even mentioned with RAA use in the SOC? This is partially political but also driven my money. Have afrezza as Step 1 and T2s do not progress to Steps 2 through 4. There will no longer be a need for all the orals, SGLT2 and GLP1s. There will also no longer be a need for all the doctors specializing in neuropathy and other diabetes specialties. Afrezza would have a huge financial impact and the ADA would lose significant financial support from BP and probably go bankrupt. Then you have the social aspect. A lot of doctors are pals with their BP sales reps and like all the perks they can offer. after reading your response, sounds like it is all about the money
|
|
|
WTF
Aug 5, 2019 17:22:21 GMT -5
Post by ktim on Aug 5, 2019 17:22:21 GMT -5
Safety trails . We’ve been around fifteen yrs / the rest takes effort ‘ s they don’t need to take at this stage of the game / but one day will ! There are meaningful numbers of docs that do not agree with that. Does it make them "stupid" or perhaps merely "overly cautious"? I guess I don't feel the need to attach labels, but we all know that many doctors simply don't agree with interpretations/opinions held by many MNKD investors. If I were a physician I would be prescribing Afrezza even without the long term safety trial as I think the existing data is pretty compelling, but I'm not a physician and not all physicians would agree with my beliefs.
|
|
|
WTF
Aug 5, 2019 17:25:29 GMT -5
Post by ktim on Aug 5, 2019 17:25:29 GMT -5
do you think it is just political or does it have to do with money and perks Endos receive for prescribing the big three? Its both. For afrezza to sell via normal channels the SOC needs to be updated. Dr. Kendall has over 60 studies showing why afrezza should be Step 1 in T2 care. Is it even mentioned with RAA use in the SOC? This is partially political but also driven my money. Have afrezza as Step 1 and T2s do not progress to Steps 2 through 4. There will no longer be a need for all the orals, SGLT2 and GLP1s. There will also no longer be a need for all the doctors specializing in neuropathy and other diabetes specialties. Afrezza would have a huge financial impact and the ADA would lose significant financial support from BP and probably go bankrupt. Then you have the social aspect. A lot of doctors are pals with their BP sales reps and like all the perks they can offer.For the most part perks have dried up. That's why many docs are now simply shutting reps out of their offices.
|
|
|
Post by sayhey24 on Aug 5, 2019 17:30:04 GMT -5
Sure they have. Maybe for the corporate offices but not for the independent practices. What has dried up are the independent practices.
|
|
|
Post by dh4mizzou on Aug 5, 2019 18:37:33 GMT -5
I talked to somebody yesterday whose son goes to a hottie toddy Endo ..he can’t get on Afrezza either.. he said it’s so incredibly political. It’s like parents wanting to get their kids into the best school they want them to have these high sought after Endo’s but once you get in there you can’t change the system you have to do what he wants you to do. Sorry but if that kid was mine that "hotty toddy" endo would have one less patient.
|
|
|
Post by radgray68 on Aug 5, 2019 18:49:56 GMT -5
I don't believe perks have dried up. They just went underground. A deep dive into the financed of the doctors would be required to prove it. Nobody has the stomach for that. Hence, the cycle continues.
|
|
|
Post by stevil on Aug 5, 2019 18:58:54 GMT -5
If you want to know why a doctor doesn't prescribe, ask a doctor. There are many on here with loud voices that have no knowledge of what they speak or live in an alternate reality to the one I live in. Be careful whose voice you listen to. Really, it's not that hard to understand... Just open your ears to the ones who know what they're talking about. It will make much more sense.
|
|
|
WTF
Aug 5, 2019 19:20:46 GMT -5
via mobile
Post by sportsrancho on Aug 5, 2019 19:20:46 GMT -5
If you want to know why a doctor doesn't prescribe, ask a doctor. There are many on here with loud voices that have no knowledge of what they speak or live in an alternate reality to the one I live in. Be careful whose voice you listen to. Really, it's not that hard to understand... Just open your ears to the ones who know what they're talking about. It will make much more sense. So what are the reasons and what can be done about them? Sorry I’m sure you’ve told us before.
|
|